Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS42001631EBVENSG00000164919.11protein_codingCOX6CNoNo1345P09669
TVIS20062569HPVENSG00000164919.11protein_codingCOX6CNoNo1345P09669
TVIS20020604HPVENSG00000164919.11protein_codingCOX6CNoNo1345P09669
TVIS20020605HPVENSG00000164919.11protein_codingCOX6CNoNo1345P09669
TVIS20020606HPVENSG00000164919.11protein_codingCOX6CNoNo1345P09669
TVIS20020607HPVENSG00000164919.11protein_codingCOX6CNoNo1345P09669
TCGA Plot Options
Drug Information
GeneCOX6C
DrugBank IDDB02659
Drug NameCholic Acid
Target IDBE0003990
UniProt IDP09669
Regulation Type
PubMed IDs10592235
CitationsBerman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.
GroupsApproved
Direct ClassificationTrihydroxy bile acids, alcohols and derivatives
SMILES[H][C@@](C)(CCC(O)=O)[C@@]1([H])CC[C@@]2([H])[C@]3([H])[C@]([H])(O)C[C@]4([H])C[C@]([H])(O)CC[C@]4(C)[C@@]3([H])C[C@]([H])(O)[C@]12C
PathwaysCongenital Bile Acid Synthesis Defect Type II; Familial Hypercholanemia (FHCA); Bile Acid Biosynthesis; Zellweger Syndrome; Congenital Bile Acid Synthesis Defect Type III; 27-Hydroxylase Deficiency; Cerebrotendinous Xanthomatosis (CTX)
PharmGKBPA166160055
ChEMBLCHEMBL205596